- Home
- AGI vs HOLX Comparison
AGI vs HOLX Comparison
Compare AGI & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGI | HOLX |
|---|---|---|
| Founded | 2003 | 1985 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Electronics |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 16.6B |
| IPO Year | 2002 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AGI | HOLX |
|---|---|---|
| Price | $41.65 | $75.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 13 |
| Target Price | $44.33 | ★ $77.89 |
| AVG Volume (30 Days) | ★ 3.7M | 3.1M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.27% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $55.02 | $4.74 |
| Revenue Next Year | $13.09 | $5.03 |
| P/E Ratio | ★ $34.21 | $95.79 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $23.49 | $51.90 |
| 52 Week High | $55.41 | $75.75 |
Technical Indicators
Market Signals| Indicator | AGI | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 43.76 | 56.07 |
| Support Level | $37.37 | $75.10 |
| Resistance Level | $45.24 | N/A |
| Average True Range (ATR) | 2.20 | 0.22 |
| MACD | -0.57 | 0.02 |
| Stochastic Oscillator | 33.25 | 71.15 |
Price Performance
Historical ComparisonAbout AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.